Current status in cancer cell reprogramming and its clinical implications.
about
High-content image informatics of the structural nuclear protein NuMA parses trajectories for stem/progenitor cell lineages and oncogenic transformation.Cancer cell reprogramming to identify the genes competent for generating liver cancer stem cells.Epigenetic Contribution of High-Mobility Group A Proteins to Stem Cell Properties.Identification of protein kinase inhibitors to reprogram breast cancer cellsReprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors
P2860
Current status in cancer cell reprogramming and its clinical implications.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Current status in cancer cell reprogramming and its clinical implications.
@en
type
label
Current status in cancer cell reprogramming and its clinical implications.
@en
prefLabel
Current status in cancer cell reprogramming and its clinical implications.
@en
P2093
P2860
P1476
Current status in cancer cell reprogramming and its clinical implications.
@en
P2093
Banu Iskender
Halit Canatan
Kenan Izgi
P2860
P2888
P304
P356
10.1007/S00432-016-2258-5
P577
2016-09-12T00:00:00Z